Company Analysis

Ginkgo Bioworks Holdings, Inc. (DNA)

NYSE: DNA · Biological Products, (No Diagnostic Substances) · Boston, MA · filing with the SEC since 2020
Grade4.5
◀ Past 4.1● Present 5.1▶ Future 4.2
1 est.

Who owns Ginkgo Bioworks Holdings, Inc.

As filed with the SEC
Holders of 5% or more
4
Reshma P. Shetty holds 9.5% of Class A Common Stock, as its SCHEDULE 13D/A filed Feb 14, 2025 says.
Directors and officers
7
report now, of 23 people on the record since 2021. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
Reshma P. Shetty
SCHEDULE 13D/A · filed Feb 14, 2025 · Class A Common Stock
9.5%
Blackrock, Inc.
SCHEDULE 13G/A · filed Jul 30, 2026 · Class A Stock · 6.5% in Jul 17, 2025
7.7%
Cascade Investment, L.L.C.
SCHEDULE 13G/A · filed Nov 14, 2025 · Class A Common Stock, $0.0001 par value per share
7.5%
Viking Global Investors LP
SCHEDULE 13G/A · filed May 15, 2026 · Class A Common Stock, par value $0.0001 per share
7.1%
Austin Che
SCHEDULE 13G/A · filed Feb 14, 2025 · Class A Common Stock · reported falling below 5%
under 5%
Baillie Gifford & Co
SCHEDULE 13G/A · filed Feb 5, 2026 · Class A Common Stock · reported falling below 5%
under 5%
The Vanguard Group
SCHEDULE 13G/A · filed Mar 26, 2026 · Common Stock · reported falling below 5%, from 5.13% in Jul 29, 2025
under 5%
ARK Investment Management LLC
SCHEDULE 13G/A · filed Jan 10, 2025 · Class A Common Stock, par value $0.0001 · reported falling below 5%
under 5%
What DNA reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
BiomEdit LLC
An investee · investee · invested in, named in the 10-K filed Feb 26, 2026
Marketable Equity Securities
An investee · investee · invested in, named in the 10-K filed Feb 26, 2026
Non Marketable Equity Securities
An investee · investee · invested in, named in the 10-K filed Feb 26, 2026
Safes
An investee · investee · invested in, named in the 10-K filed Feb 26, 2026
Synlogic, Inc. Warrant
An investee · investee · invested in, named in the 10-K filed Feb 26, 2026
AgBiome, Inc.
A company bought · acquisition · owns, named in the 10-K filed Feb 26, 2026
Circularis
A company bought · acquisition · owns, named in the 10-K filed Feb 26, 2026
Stridebio
A company bought · asset acquisition · owns, named in the 10-K filed Feb 26, 2026

4 subsidiaries in 1 country, from the list filed with the 10-K filed Feb 26, 2026.

Insider tradesForm 4
19sales
0purchases
0sales on a scheduled plan
4people selling
$3.6Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Oct 21, 2025 to Oct 21, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2223242526
2026 runs to Oct 21, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window5 of 34 on the roster
PersonRole as filedSalesSoldOn a planBuysBought
Kelly Jason RSee remarks3$1.8M00$0
Shetty Reshma P.See remarks5$1.4M00$0
Canton Barry10% owner5$1.4M00$0
Coen Steven P.See remarks10$300,00000$0
Henry Christian Odirector1$000$0
SI Assistanton DNA · research, not advice